Cilostazol Conduction Effects

e n s e s / b y -n c -n d / 4 .0 / ) .velocity, and improved hemodynamics in patients with HFpEF from heart rate-mediated effects.In the case by Aryal et al, 1 the rapid improvement in AV conduction temporally after initiating cilostazol aligns with the drug's reported effects.While spontaneous recovery is common in Lyme carditis, cilostazol's potential mechanisms-shortening AV nodal refractoriness, attenuating adenosinemediated suppression, and enhancing nodal automaticity-may have accelerated the recovery process.Cilostazol's oral formulation, relative safety, and physiologic profile position it as a potential adjunctive therapy in selected patients with reversible conduction disturbances.The present case provides interesting evidence that cilostazol may serve as a useful adjunct for reversible AV conduction system disease.Cilostazol's chronotropic and dromotropic effects warrant further systematic study as a targeted bridge for conduction system disease where full recovery is expected.